Navigation Links
Cardiome to Release Third Quarter Results
Date:11/6/2009

NASDAQ: CRME TSX: COM

VANCOUVER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the third quarter ended September 30, 2009 on the morning of Monday, November 9, 2009. Cardiome will hold a teleconference call and webcast at 9:00am Eastern (6:00am Pacific) on that day to discuss the results.

To access the conference call, please dial 416-695-7806 or 888-789-9572 and reference conference 2345242. There will be a separate dial-in line for analysts on which we will respond to questions at the end of the call. The webcast can be accessed through Cardiome's website at www.cardiome.com.

Webcast and telephone replays of the conference call will be available approximately two hours after the completion of the call through December 9, 2009. Please dial 416-695-5800 or 800-408-3053 and enter code 3147267 followed by the number sign to access the replay.

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ National Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be b
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Cardiome to Present at Bear Stearns Conference
2. Cardiome to Present at ThinkEquity Conference
3. Cardiome to Present at CIBC Conference
4. Cardiome To Release Third Quarter Results
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. Cardiome Updates Guidance
7. Cardiome to Hold Investor Update Call
8. Cardiome And Astellas Announce Regulatory Update
9. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
10. Cardiome To Release 2007 Results
11. Cardiome To Release 2008 First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...d arthritis, could help newly diagnosed diabetics,...lthDay News) -- A drug commonly used to treat non-...so shows some promise in helping patients newly di...imab (Rituxan), helped patients keep producing som...d destroyed some of their pancreatic beta cells, w...
(Date:11/25/2009)...ONSkincare ®isproudtosupportGNC,seffortstorai...t.Jude ThanksandGiving campaign,$1fromthepurchasep...Balm willbedonatedtoSt.Jude.Additionally,GNCcustom...eckoutatoneoftheir5,000+retaillocationsoratGNC.com...heir2009 ThanksandGiving campaign. ,, "Wearedel...
(Date:11/25/2009)...ccur in children with autism and related condition...es medication combined with a structured training ...researchers and their colleagues. , Published i...merican Academy of Child and Adolescent Psychiatry...te of Mental Health (NIMH) Research Units on Pedia...
(Date:11/25/2009)...e premier resource for life science careers and in...rest™ Hotbed Campaign this morning. , ...25, 2009 -- BioSpace.com, the premier resource for...e third edition of the BioForest™ Hotbed Cam...n is a promotional effort highlighting biotechnolo...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
... across the Yangtze River will take another two ye...ready changing the local weather, claim scientists... data suggest that the reservoir is cooling the Ya...ty of Maryland in College Park have collaborated w...
...consider home to be the safest place for deliverie...t their children immunised. The Gandhi M...egions of Udaipur district, conducted the study of...ording to the findings, around 94 percent of pregn...
...ons of insect love and desire. The cicada's songs ... how an emitting sex attracts conspecific members...though less conspicuous for us humans, are also si...thought to play a major role in the evolution of m...
..., Volodymyr Tarabara and Tom Voice, are leading an... Tarabara and Voice are leading an internatio...entists from two U.S. research universities, two r...nding of its kind a $2.5 million grant by the Na...
...e of humour or great look is whats really needed t...sing skills . A poll by online dating agenc...umped a lover because they were a miserable kisser... relationship. This was followed by using ...
...s drug dealer has revealed secrets about the singe... The singer and McFadden Kitten split two years ag... daughters Molly, 4, and Lilly Sue, 3. A...out drugs than anything in her life her children,...
Other Medicine News:Health News:China's Three Gorges Dam Changing Local Weather: Scientists 2Health News:Poor Health Practices Plague Rajasthan Tribal Women 2Health News:Another Sexual Attraction is Possible ... 2Health News:Two MSU Professors Spearhead International Water Project 2Health News:Two MSU Professors Spearhead International Water Project 3Health News:Drugs More Important Than Kids for Katona, Says Her Candy Man 2
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comann...catalogue: ,, PainManagement-GlobalTrends ,...nagement---Global-Trends.html ,, Widespreadava...linics,andtheadventofnewdrugshaveacceleratedthepac...msandreimbursementstructurecontinuetoshapedemandfo...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Chemo...datafromtheCompany,sPROTECT-1(theProspectiveRandom...raficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-...thafavorablesafetyandtolerabilityprofile.Thestudyd...nofdiseaseseverityasdefinedasa70-pointdecreaseinth...
(Date:11/24/2009)..., MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--Ques...dingproviderofdiagnostictesting,informationandserv...ualPiperJaffrayHealthcareConferenceinNewYorkCity.T...09at9:30a.m.EasternTime. ,, Duringtheconference...owthtoapproximate3%,operatingincometoexceed18%ofre...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Stimulus funding helps K State biochemist study eyes lens in diabetes galactosemia patients 9528 1DynaVox Mayer Johnson Announces the Xpress 54073 1DynaVox Mayer Johnson Announces the Xpress 54073 2DynaVox Mayer Johnson Announces the Xpress 54073 3Hypertronics HyperGrip 28R 29 and D Series Connectors Selected for SynCardias Total Artificial Heart 54069 1Hypertronics HyperGrip 28R 29 and D Series Connectors Selected for SynCardias Total Artificial Heart 54069 2
...N, DC, June 11, 2007 /PRNewswire-FirstCall/ - Paul...ne at Georgetown,University Medical Center, and pr...chem Inc.,s North American Phase III clinical tria...ay an update on,Neurochem,s investigational produc...se (AD). The presentation by Dr. Aisen will take,p...
...tabine achieved both primary and secondary endpoin... observed between,valopicitabine and ribavirin ~, ...all/ -- Idenix,Pharmaceuticals, Inc. today announc...ate triple combination therapy, consisting of,valo...or the,treatment of hepatitis C, pegylated interfe...
Other Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6
...ities where space is a premium Fabius Tiro combine...gies with an ergonomic and compact design. Adding ...nfinity patient monitoring range allows you to cre...nd investment into the future. The open modular ar...
... using Datex-Ohmedas unique approach to anesthesia...laboration with clinicians. It combines the proven...eda monitoring technology into an affordable syste...world, ,The contemporary, compact design addresse...
...nt Wound Dressing is a sterile, single use bundle ...g applications. The synthetic matrix absorbs exce...ontours, and entraps slough and necrotic debris wi...rands of the matrix are bound together by a matrix...
...sician preference card system as well as a perpetu...management requirements of the surgical services d...h a broad array of inventory management capabiliti...e supply and charge capture workflow. Regardless o...
Medicine Products: